2018
DOI: 10.1186/s13023-018-0826-2
|View full text |Cite
|
Sign up to set email alerts
|

What’s new in pontocerebellar hypoplasia? An update on genes and subtypes

Abstract: BackgroundPontocerebellar hypoplasia (PCH) describes a rare, heterogeneous group of neurodegenerative disorders mainly with a prenatal onset. Patients have severe hypoplasia or atrophy of cerebellum and pons, with variable involvement of supratentorial structures, motor and cognitive impairments. Based on distinct clinical features and genetic causes, current classification comprises 11 types of PCH.Main textIn this review we describe the clinical, neuroradiological and genetic characteristics of the different… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
119
0
14

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 126 publications
(137 citation statements)
references
References 111 publications
(202 reference statements)
4
119
0
14
Order By: Relevance
“…There is no curative treatment for PCH and patients rarely survive to adulthood (36). PCH is grouped into 11 subtypes based on phenotypic characteristics such as severe hypoplasia, trouble swallowing, progressive microcephaly, and motor and cognitive impairments (37). A mutation within CLP1 is linked to class PCH10 (34,38,39), while mutations in TSEN2, TSEN15, TSEN34, and TSEN54 are associated with PCH2, PCH4, and PCH5 (32,40).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…There is no curative treatment for PCH and patients rarely survive to adulthood (36). PCH is grouped into 11 subtypes based on phenotypic characteristics such as severe hypoplasia, trouble swallowing, progressive microcephaly, and motor and cognitive impairments (37). A mutation within CLP1 is linked to class PCH10 (34,38,39), while mutations in TSEN2, TSEN15, TSEN34, and TSEN54 are associated with PCH2, PCH4, and PCH5 (32,40).…”
Section: Introductionmentioning
confidence: 99%
“…The other PCH subtypes are linked to mutations in other genes, many of which are associated with RNA processing and maturation (37,(41)(42)(43). The underlying cause of PCH is unknown, but the association of PCH with several RNA processing enzymes suggests a link between disruption of RNA processing and neurological disorders.…”
Section: Introductionmentioning
confidence: 99%
“…The majority of PCH cases have been linked to mutations in genes important for tRNA metabolism. In particular, 60% for all genetically defined cases of PCH are caused by mutations in the genes encoding for protein subunits of the TSEN complex (31,33,34,35,36). The main function accomplished by the TSEN complex is to produce mature and functional tRNAs by removing an intron.…”
Section: Biorxivmentioning
confidence: 99%
“…A number of missense mutations that cause single amino acid substitutions in conserved regions of EXOSC3 have been linked to PCH1b [6]. Of note, clinical reports indicate that the severity of PCH1b pathology is influenced by EXOSC3 allelic heterogeneity, suggesting a genotype-phenotype correlation [6,[21][22][23]. These observations indicate that EXOSC3 plays a critical role in the brain and suggest specific functional consequences for amino acid changes linked to disease.…”
Section: Introductionmentioning
confidence: 97%